S1PR4 and neoplasm: As for S1PR4, a clinical study has shown that higher tumor expressions of SPHK1 and S1PR4 are associated with shorter disease-free survival and more advanced lymph node status in ER-negative breast cancer patients (Ohotski et al., 2012).